In melanoma cells, a signaling pathway amplifies the action of fisetin.39Human melanoma cells that are BRAF mutants grow significantly more slowly when fisetin and the BRAF inhibitor sorafenib are applied together. The gene discussed is BRAF; the disease is melanoma.